Sign in

Jasmine Sukumar MD

@jasminesukumar.bsky.social
65 followers 55 following 0 posts

Breast Medical Oncologist @mdanderson.bsky.social #bcsm #oncsky

PostsRepliesMedia
Reposted by Jasmine Sukumar MD
Dionisia Quiroga, DO, PhD, FASCO @quirogad.bsky.social · 02/02/2025
🎉Reunion w/ my co-fellow @jasminesukumar.bsky.social @mdanderson.bsky.social to discuss early #breastcancer adj tx w/ path germline muts on the @ascocancer.bsky.social Daily News podcast 👉Who needs testing? 👉OLYMPIA updates 👉Concurrent PARPi use w/ other adj tx ascodaily.libsyn.com/advances-in-...
ascodaily.libsyn.com
ASCO Daily News: Advances in Adjuvant Therapy for High-Risk Early Breast Cancer With Germline Mutations
Dr. Jessica Sukumar and Dr. Dionisia Quiroga discuss advances in adjuvant therapy for patients with early breast cancer and BRCA1/2 mutations, including how to identify patients who should receive gen...
053
Reposted by Jasmine Sukumar MD
Yüksel Ürün @yukselurun.bsky.social · 17/01/2025
🔻 Cancer mortality declined, averting 4.5M deaths since 1991, thanks to smoking reduction, earlier detection, & better treatments. 🔺 However, alarming disparities persist 🚺 Cancer incidence is rising in women @oncoalert.bsky.social acsjournals.onlinelibrary.wiley.com/doi/full/10....
052
Reposted by Jasmine Sukumar MD
Tatiana Prowell, MD @tmprowell.bsky.social · 12/12/2024
#SABCS24 #bcsm #OncSky 🧵 COMET study randomized 957 F age 40+ w/ low risk ER+ #DCIS to guideline-concordant care (GCC, immed surgery etc) or active monitoring (AM, serial imaging-> bx/surg etc). At 2y, AM non-inferior to GCC for invasive #breastcancer, BUT important details… @oncoalert.bsky.social
1187
Reposted by Jasmine Sukumar MD
Erika Hamilton MD, FASCO @erikahamilton9.bsky.social · 12/12/2024
It's a difficult topic to discuss- weight. Hugely personal, not easy to change, but impt. 4% ⬆️ recurrence in pts w/ node + #bcsm obese vs. lean 2% ⬆️ recurrence in pts with N0 dz 📌Magnitude of effect larger among premeno. 📌ER + AND ER neg @sabcs.bsky.social #SABCS24 @oncoalert.bsky.social
0217
Reposted by Jasmine Sukumar MD
Tatiana Prowell, MD @tmprowell.bsky.social · 13/12/2024
#SABCS24 #bcsm #OncSky #MedSky 📣 A germline variant in PCSK9 (V474I) is assoc w/ #breastcancer survival & causally drives mets (targets tumoral LRP1 & induces somatic pro-mets gene expression). PCSK9 inhibition (used to ⬇️ cholesterol) ⬇️ mets. @oncoalert.bsky.social www.cell.com/cell/abstrac...
cell.com
A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor
Characterization of a common germline variant in PCSK9 unveils a hereditary basis underlying breast cancer metastasis and suggests that PCSK9 inhibition therapy could be a promising strategy for breast cancer metastasis prevention.
0204
Reposted by Jasmine Sukumar MD
Ilana Schlam @ilanaschlam.bsky.social · 13/12/2024
Wrapping up another fantastic #SABCS! Amazing, practice-changing data were presented. I’ve updated the algorithms and added key studies from the meeting— I finally ran out of space in HR+ disease! #SABCS24 @oncoalert.bsky.social
04619
Reposted by Jasmine Sukumar MD
Yale Cancer Center @yalecancer.bsky.social · 12/12/2024
@maryamlustberg.bsky.social presents a summary of survivorship poster presentations #SABCS24 “Health promotion should be done in collaboration with our patients and should not create extra stress for them.” #bcsm @sabcs.bsky.social @yaleschoolofmed.bsky.social
0123